NeuroNova AB has been acquired by a public company.
PrivCo has ceased its coverage of NeuroNova AB and below is the archived report.
NeuroNova AB, a biopharmaceutical company, engages in the development and commercialization of therapies for the treatment of central nervous system disorders. It was acquired by Newron Pharmaceuticals, a public company, in June 2012.
Overview & Corporate Organization
PrivCo Industries (Sector > Industry > Sub-Industry)
|Healthcare > Pharmaceuticals|
|Technology > Biotechnology|
The PrivCo Industry Classification System™ (PICS) is our proprietary, modernized industry classification system, geared especially toward privately-held companies and including newer emerging sub-industries that are not reflected in other outdated industry classification systems, such as SIC and NAICS.
Mergers & Acquisitions
Direct Share Purchase
|1||Investor AB and HealthCap, holders...Read More →|
Missing a deal? Tell us about it! firstname.lastname@example.org